当前位置: 首页 » 政策法规 » 国外法规 »(EU) No 1162/2010:拒绝批准某些用于食品涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods and referring to the reduction of disease risk and to children’s development and health)

(EU) No 1162/2010:拒绝批准某些用于食品涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods and referring to the reduction of disease risk and to children’s development and health)

扫描二维码 分享好友和朋友圈
放大字体  缩小字体 2015-01-30 01:22:53  来源:EUROPE  浏览次数:3291
核心提示::2010年12月10日,欧盟发布委员会条例(EU) No 1162/2010,拒绝批准2种食品健康声称:1) Immunofortis®可自然增强机体免疫系统功能。2)Eye qTM(高含量的欧米伽-3,6多不饱和脂肪酸EPA/DHA/GLA的特定组合产品)可提供有助改善儿童“工作记忆”的必需营养素。
发布单位
EUROPEAN COMMISSION
EUROPEAN COMMISSION
发布文号 (EU) No 1162/2010
发布日期 2010-12-10 生效日期 暂无
有效性状态 废止日期 暂无
备注 2010年12月10日,欧盟发布委员会条例(EU) No 1162/2010,拒绝批准2种食品健康声称:1) Immunofortis®可自然增强机体免疫系统功能。2)Eye qTM(高含量的欧米伽-3,6多不饱和脂肪酸EPA/DHA/GLA的特定组合产品)可提供有助改善儿童“工作记忆”的必需营养素。

  COMMISSION REGULATION (EU) No 1162/2010

  of 9 December 2010

  refusing to authorise certain health claims made on foods and referring to the reduction of disease risk and to children’s development and health

  (Text with EEA relevance)

  THE EUROPEAN COMMISSION,

  Having regard to the Treaty on the Functioning of the European Union,

  Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (1), and in particular Article 17(3) thereof,

  Whereas:

  (1)

  Pursuant to Regulation (EC) No 1924/2006 health claims made on food are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.

  (2)

  Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State. The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as the Authority.

  (3)

  Following receipt of an application the Authority is to inform without delay the other Member States and the Commission of the application, and to deliver an opinion on the health claim concerned.

  (4)

  The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.

  (5)

  The two opinions referred to in this Regulation are related to applications for health claims referring to children’s development and health, as referred to in Article 14(1)(b) of Regulation (EC) No 1924/2006.

  (6)

  Following an application from Danone Baby Nutrition, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Immunofortis? on the infant’s immune system (Question No EFSA-Q-2008-106) (2). The claim proposed by the applicant was worded as follows: ‘Immunofortis? to naturally strengthen your baby’s immune system’.

  (7)

  On the basis of the data presented, the Authority concluded in its opinion received by the Commission and the Member States on 4 February 2010 that the information provided is insufficient to establish a cause and effect relationship between the consumption of Immunofortis? and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

  (8)

  Following an application from Vifor Pharma (Potters), submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Eye qTM on working memory (Question No EFSA-Q-2009-00485) (3). The claim proposed by the applicant was worded as follows: ‘Eye q TM (a unique combination of High-EPA/DHA/GLA omega-3, 6 PUFA) provides the essential nutrients that helps improve working memory in children’. The abbreviations used by the applicant refer respectively to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), gamma-linolenic acid (GLA) and polyunsaturated fatty acids (PUFA).

  (9)

  On the basis of the data presented, the Authority concluded in its opinion received by the Commission and the Member States on 4 March 2010 that the information provided is insufficient to establish a cause and effect relationship between the intake of Eye q TM and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

  (10)

  In accordance with Article 28(6) of Regulation (EC) No 1924/2006, health claims referred to in its Article 14(1)(b) and not authorised by a decision pursuant to Article 17(3) of Regulation (EC) No 1924/2006 may continue to be used for 6 months after the adoption of this Regulation, provided an application was made before 19 January 2008. However, as the health claim application relevant to Eye qTM was not made before 19 January 2008 the requirement provided for in Article 28(6)(b) is not fulfilled, and the transition period laid down in that Article is not applicable. Accordingly, a transition period of 6 months should be provided for, to enable food business operators to adapt to the requirements laid down in this Regulation.

  (11)

  The comments from the applicants and the members of the public received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006 have been considered when setting the measures provided for in this Regulation.

  (12)

  The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health and neither the European Parliament nor the Council have opposed them,

  HAS ADOPTED THIS REGULATION:

  Article 1

  The health claims set out in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 14(1) of Regulation (EC) No 1924/2006.

  However, they may continue to be used for 6 months after the entry into force of this Regulation.

  Article 2

  This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.

  This Regulation shall be binding in its entirety and directly applicable in all Member States.

  Done at Brussels, 9 December 2010.

  For the Commission

  The President

  José Manuel BARROSO
 

Rejected health claims
Application – Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 14(1)(b) health claim referring to children’s development and health
Immunofortis®
Immunofortis® to naturally strengthen your baby’s immune system
Q-2008-106
Article 14(1)(b) health claim referring to children’s development and health
Eye qTM
Eye qTM (a unique combination of High-EPA/DHA/GLA omega-3, 6 PUFA) provides the essential nutrients that helps improve working memory in children
Q-2009-00485



 

食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务。
电询:0535-2129301
QQ:2891238009
食品标法圈
实时把握食品标法动态
请扫码关注食品标法圈

声明:

① 凡本网所有原始/编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”。
② 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。
※ 邮箱:law#foodmate.net(发邮件时请将#换成@) QQ:139307733

 
 
[ 政策法规搜索 ]  [ 加入收藏 ]  [ 告诉好友 ]  [ 打印本文 ]  [ 关闭窗口 ]

 

 
 
按分类浏览
国家法规 (11359) 国外法规 (3603)
地方法规 (39752) 法规动态 (210)
法规解读 (2623) 其他法规 (506)
推荐国外法规
点击排行
按国家或地区浏览

法规中心  关于我们  广告业务  联系我们  信息服务

Processed in 0.303 second(s), 10 queries, Memory 4.48 M